Using a patented magnetic closure, Babynetic's bibs are designed to snap and stay secured while holding up to four pounds of food. Photo courtesy of Babynetic

Ashley Gooch has taken her entrepreneurial spirit from the fitness studio to the finger foods.

The Houston-based founder of high-end cycling studio RYDE and mom of three has launched a new baby gear brand, Babynetic. The company debuted its first product this month: the Babynetic bib.

Using a patented magnetic closure, the colorful platinum-grade silicone bibs are designed to snap and stay secured while holding up to four pounds of food. The snap is intended to be easy for parents to use, but more difficult for messy little hands to remove without assistance.

Thanks to their magnetic snap, the bibs can also be stored or hung on the fridge or dishwasher for easy access for busy parents and caregivers. The smooth silicone (free of BPA, BPS, phthalate and PVC) is intended to be easy to wipe down and clean and comes in a variety of bold fruit-inspired colors.

The product was born out of necessity for Gooch and her Austin-based business partner and fellow mom Jennifer Zimmer. The duo met while attending Texas A&M University. Zimmer currently works full-time as a customer success manager for the Central South region at California-based software development firm Workday, according to her LinkedIn.

“As busy moms ourselves juggling careers and with five kids between us, we needed baby gear we could rely on,” Gooch said in a statement.

“All of our kids could pull of their bibs at mealtime,” Zimmer added.

Gooch and Zimmer worked with product Los Angeles-based full-stack produce development company Mvnifest to prototype and build the line. Mvnifest was launched by Samantha Rose, founder and CEO of Sorry Robots, who got her start designing a silicone kitchen spatula, eventually growing into a full line of kitchen tools known as the brand GIR.

Babynetic is currently taking orders for the Babynetic bibs on its website, and shipping began last week on April 24. By Spring 2025, the team aims to release baby onesies that feature their patented magnetic closure.

“We wanted people to use Babynetic products and think, ‘This is so much better,’” Gooch said.

Ashley Gooch (right) co-founded the company with Austin-based business partner and fellow mom Jennifer Zimmer. Photo courtesy of Babynetic

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Nominations are now open for the 2025 Houston Innovation Awards

Calling All Innovators

Calling all Houston innovators: The Houston Innovation Awards return this fall to celebrate the best and brightest in the Houston innovation ecosystem right now.

Presented by InnovationMap, the fifth annual Houston Innovation Awards will take place November 5 at TMC Helix Park.

The awards program will honor the top startups and innovators in Houston across 10 categories, and we're asking you to nominate the most deserving Houston innovators and innovative companies today.

This year's categories are:

  • Minority-founded Business, honoring an innovative startup founded or co-founded by BIPOC or LGBTQ+ representation.
  • Female-founded Business, honoring an innovative startup founded or co-founded by a woman.
  • Energy Transition Business, honoring an innovative startup providing a solution within renewables, climatetech, clean energy, alternative materials, circular economy, and beyond.
  • Health Tech Business, honoring an innovative startup within the health and medical technology sectors.
  • Deep Tech Business, honoring an innovative startup providing technology solutions based on substantial scientific or engineering challenges, including those in the AI, robotics, and space sectors.
  • Startup of the Year (People's Choice), honoring a startup celebrating a recent milestone or success. The winner will be selected by the community via an interactive voting experience.
  • Scaleup of the Year, honoring an innovative later-stage startup that's recently reached a significant milestone in company growth.
  • Incubator/Accelerator of the Year, honoring a local incubator or accelerator that is championing and fueling the growth of Houston startups.
  • Mentor of the Year, honoring an individual who dedicates their time and expertise to guide and support budding entrepreneurs.
  • Trailblazer, honoring an innovator who's made a lasting impact on the Houston innovation community.

Nominations may be made on behalf of yourself, your organization, and other leaders in the local innovation scene. The nomination period closes on August 31, so don't delay — nominate today at this link, or fill out the embedded form below.

Our panel of esteemed judges will review the nominations, and determine the finalists and winners. Finalists will be unveiled on September 30, and the 2025 Houston Innovation Awards winners will be announced live at our event on November 5.

Tickets will go on sale this fall. Stay tuned for that announcement, as well as more fanfare leading up to the 2025 Houston Innovation Awards.

Nominate now:

Interested in Innovation Awards sponsorship opportunities? Please contact sales@innovationmap.com.

MD Anderson launches $10M collaboration to advance personalized cancer treatment tech

fighting cancer

The University of Texas MD Anderson Cancer Center and Japan’s TOPPAN Holdings Inc. have announced a strategic collaboration to co-develop TOPPAN Holdings’ 3D cell culture, or organoid, technology known as invivoid.

The technology will be used as a tool for personalized cancer treatments and drug screening efforts, according to a release from MD Anderson. TOPPAN has committed $10 million over five years to advance the joint research activities.

“The strategic alliance with MD Anderson paves a promising path toward personalized cancer medicine," Hiroshi Asada, head of the Business Innovation Center at TOPPAN Holdings, said in a news release.

Invivoid is capable of establishing organoid models directly from patient biopsies or other tissues in a way that is faster and more efficient. Researchers may be able to test a variety of potential treatments in the laboratory to understand which approach may work best for the patient, if validated clinically.

“Organoids allow us to model the three-dimensional complexity of human cancers in the lab, thus allowing us to engineer a powerful translational engine—one that could not only predict how patients will respond to therapy before treatment begins but also could help to reimagine how we discover and validate next-generation therapies," Dr. Donna Hansel, division head of pathology and laboratory medicine at MD Anderson, added in the news release. “Through this collaboration, we hope to make meaningful progress in modeling cancer biology for therapeutic innovation.”

The collaboration will build upon preclinical research previously conducted by MD Anderson and TOPPAN. The organizations will work collaboratively to obtain College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) certifications for the technology, which demonstrate a commitment to high-quality patient care. Once the certifications are obtained, they plan to conduct observational clinical studies and then prospective clinical studies.

“We believe our proprietary invivoid 3D cell culture technology, by enabling the rapid establishment of organoid models directly from patient biopsies, has strong potential to help identify more effective treatment options and reduce the likelihood of unnecessary therapies,” Asada added in the release. “Through collaboration on CAP/CLIA certification and clinical validation, we aim to bring this innovation closer to real-world patient care and contribute meaningfully to the advancement of cancer medicine."